Page last updated: 2024-08-22

vidarabine and Osteosarcoma

vidarabine has been researched along with Osteosarcoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cole, PD; Kamen, BA; Smith, AK1
Ijichi, O; Ikarimoto, N; Ishikawa, S; Kawano, Y; Kodama, Y; Manago, K; Nishikawa, T; Okamoto, Y; Shinkoda, Y; Tanabe, T1
Gojkovic, Z; Hasholt, L; Joergensen, T; Knecht, W; Le Breton, C; Munch-Petersen, B; Piskur, J; Rozpedowska, E; Sandrini, MP; Willer, M1
ter Meulen, V1

Reviews

1 review(s) available for vidarabine and Osteosarcoma

ArticleYear
[Present state of antiviral therapy (author's transl)].
    Monatsschrift fur Kinderheilkunde, 1979, Volume: 127, Issue:6

    Topics: Amantadine; Antiviral Agents; Child; Cytarabine; Encephalitis; Herpes Simplex; Humans; Idoxuridine; Influenza, Human; Interferons; Keratitis, Dendritic; Osteosarcoma; Ribavirin; Smallpox; Thiosemicarbazones; Vidarabine

1979

Other Studies

3 other study(ies) available for vidarabine and Osteosarcoma

ArticleYear
Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Bone Neoplasms; Cattle; Culture Media; Cytarabine; Dialysis; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Fetal Blood; Humans; Hypoxanthine; Methotrexate; Neoplasm Proteins; Nucleotides; Osteosarcoma; Tetrahydrofolate Dehydrogenase; Thymidine; Tumor Cells, Cultured; Vidarabine

2002
Rapid progression of metastatic osteosarcoma after initiation of a reduced-intensity conditioning regimen with immunosuppressive fludarabine.
    Pediatric transplantation, 2006, Volume: 10, Issue:7

    Topics: Antineoplastic Agents; Bone Neoplasms; Child; Disease Progression; Fatal Outcome; Female; Humans; Immunosuppression Therapy; Magnetic Resonance Imaging; Myeloablative Agonists; Osteosarcoma; Pleural Neoplasms; Radiography, Thoracic; Vidarabine

2006
Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.
    Gene therapy, 2007, Volume: 14, Issue:17

    Topics: Animals; Antimetabolites; Antineoplastic Agents; Cell Line, Tumor; Cladribine; Cytarabine; Directed Molecular Evolution; Drosophila melanogaster; Genes, Transgenic, Suicide; Genetic Therapy; Glioblastoma; Humans; Lethal Dose 50; Mutation; Neoplasms; Osteosarcoma; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Purines; Substrate Specificity; Transduction, Genetic; Vidarabine

2007